{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T01:50:57Z","timestamp":1777773057311,"version":"3.51.4"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,29]]},"DOI":"10.7759\/cureus.107978","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T17:13:47Z","timestamp":1777482827000},"source":"Crossref","is-referenced-by-count":0,"title":["All That Swells Is Not Allergy: Unmasking Rhino-Orbital-Cerebral Mucormycosis in Diabetic Ketoacidosis"],"prefix":"10.7759","author":[{"given":"Carlos","family":"Fagundo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hazem","family":"Abugrara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1254919","article-title":"Mucormycosis in 2023: an update on pathogenesis and management","volume":"13","author":"Alqarihi A","year":"2023","unstructured":"Alqarihi A, Kontoyiannis DP, Ibrahim AS. Mucormycosis in 2023: an update on pathogenesis and management. Front Cell Infect Microbiol. 2023, 13:1254919. 10.3389\/fcimb.2023.1254919","journal-title":"Front Cell Infect Microbiol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1751","article-title":"EORTC\/MSGERC definitions of invasive fungal diseases: summary of activities of the intensive care unit working group","volume":"72","author":"Bassetti M","year":"2021","unstructured":"Bassetti M, Azoulay E, Kullberg BJ, et al.. EORTC\/MSGERC definitions of invasive fungal diseases: summary of activities of the intensive care unit working group. Clin Infect Dis. 2021, 72:S121-7. 10.1093\/cid\/ciaa1751","journal-title":"Clin Infect Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(19)30312-3","article-title":"Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium","volume":"19","author":"Cornely OA","year":"2019","unstructured":"Cornely OA, Alastruey-Izquierdo A, Arenz D, et al.. Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium. Lancet Infect Dis. 2019, 19:e405-21. 10.1016\/S1473-3099(19)30312-3","journal-title":"Lancet Infect Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.2003.016030","article-title":"Presentation and outcome of rhino-orbital-cerebral mucormycosis in patients with diabetes","volume":"80","author":"Bhansali A","year":"2004","unstructured":"Bhansali A, Bhadada S, Sharma A, et al.. Presentation and outcome of rhino-orbital-cerebral mucormycosis in patients with diabetes. Postgrad Med J. 2004, 80:670-4. 10.1136\/pgmj.2003.016030","journal-title":"Postgrad Med J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.18.3.556-569.2005","article-title":"Novel perspectives on mucormycosis: pathophysiology, presentation, and management","volume":"18","author":"Spellberg B","year":"2005","unstructured":"Spellberg B, Edwards J Jr, Ibrahim A. Novel perspectives on mucormycosis: pathophysiology, presentation, and management. Clin Microbiol Rev. 2005, 18:556-69. 10.1128\/CMR.18.3.556-569.2005","journal-title":"Clin Microbiol Rev"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir880","article-title":"A global analysis of mucormycosis in France: the RetroZygo study (2005-2007)","volume":"54","author":"Lanternier F","year":"2012","unstructured":"Lanternier F, Dannaoui E, Morizot G, et al.. A global analysis of mucormycosis in France: the RetroZygo study (2005-2007). Clin Infect Dis. 2012, 54:S35-43. 10.1093\/cid\/cir880","journal-title":"Clin Infect Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2018.07.011","article-title":"The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports","volume":"25","author":"Jeong W","year":"2019","unstructured":"Jeong W, Keighley C, Wolfe R, Lee WL, Slavin MA, Kong DC, Chen SC. The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports. Clin Microbiol Infect. 2019, 25:26-34. 10.1016\/j.cmi.2018.07.011","journal-title":"Clin Microbiol Infect"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s13244-021-01109-z","article-title":"Rhino-orbito-cerebral mucormycosis: pictorial review","volume":"12","author":"Pai V","year":"2021","unstructured":"Pai V, Sansi R, Kharche R, Bandili SC, Pai B. Rhino-orbito-cerebral mucormycosis: pictorial review. Insights Imaging. 2021, 12:167. 10.1186\/s13244-021-01109-z","journal-title":"Insights Imaging"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0160897","article-title":"Early differential diagnosis of rhino-orbito-cerebral mucormycosis and bacterial orbital cellulitis: based on computed tomography findings","volume":"11","author":"Son JH","year":"2016","unstructured":"Son JH, Lim HB, Lee SH, Yang JW, Lee SB. Early differential diagnosis of rhino-orbito-cerebral mucormycosis and bacterial orbital cellulitis: based on computed tomography findings. PLoS One. 2016, 11:e0160897. 10.1371\/journal.pone.0160897","journal-title":"PLoS One"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1086\/589857","article-title":"Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis","volume":"47","author":"Reed C","year":"2008","unstructured":"Reed C, Bryant R, Ibrahim AS, Edwards J Jr, Filler SG, Goldberg R, Spellberg B. Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis. Clin Infect Dis. 2008, 47:364-71. 10.1086\/589857","journal-title":"Clin Infect Dis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/mmy\/myx101","article-title":"Challenges in the diagnosis and treatment of mucormycosis","volume":"56","author":"Skiada A","year":"2018","unstructured":"Skiada A, Lass-Floerl C, Klimko N, Ibrahim A, Roilides E, Petrikkos G. Challenges in the diagnosis and treatment of mucormycosis. Med Mycol. 2018, 56:93-101. 10.1093\/mmy\/myx101","journal-title":"Med Mycol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms9071518","article-title":"Microbiological and molecular diagnosis of mucormycosis: from old to new","volume":"9","author":"Lackner N","year":"2021","unstructured":"Lackner N, Posch W, Lass-Fl\u00f6rl C. Microbiological and molecular diagnosis of mucormycosis: from old to new. Microorganisms. 2021, 9:1518. 10.3390\/microorganisms9071518","journal-title":"Microorganisms"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/jof8050457","article-title":"Recent developments in the diagnosis of mucormycosis","volume":"8","author":"Dannaoui E","year":"2022","unstructured":"Dannaoui E. Recent developments in the diagnosis of mucormycosis. J Fungi (Basel). 2022, 8:457. 10.3390\/jof8050457","journal-title":"J Fungi (Basel)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/jof6040265","article-title":"Epidemiology and diagnosis of mucormycosis: an update","volume":"6","author":"Skiada A","year":"2020","unstructured":"Skiada A, Pavleas I, Drogari-Apiranthitou M. Epidemiology and diagnosis of mucormycosis: an update. J Fungi (Basel). 2020, 6:265. 10.3390\/jof6040265","journal-title":"J Fungi (Basel)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2010.03456.x","article-title":"Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007","volume":"17","author":"Skiada A","year":"2011","unstructured":"Skiada A, Pagano L, Groll A, et al.. Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007. Clin Microbiol Infect. 2011, 17:1859-67. 10.1111\/j.1469-0691.2010.03456.x","journal-title":"Clin Microbiol Infect"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/1469-0691.12371","article-title":"ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013","volume":"20","author":"Cornely OA","year":"2014","unstructured":"Cornely OA, Arikan-Akdagli S, Dannaoui E, et al.. ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013. Clin Microbiol Infect. 2014, 20:5-26. 10.1111\/1469-0691.12371","journal-title":"Clin Microbiol Infect"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1086\/432579","article-title":"Epidemiology and outcome of zygomycosis: a review of 929 reported cases","volume":"41","author":"Roden MM","year":"2005","unstructured":"Roden MM, Zaoutis TE, Buchanan WL, et al.. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005, 41:634-53. 10.1086\/432579","journal-title":"Clin Infect Dis"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1086\/590004","article-title":"Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis","volume":"47","author":"Chamilos G","year":"2008","unstructured":"Chamilos G, Lewis RE, Kontoyiannis DP. Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis. Clin Infect Dis. 2008, 47:503-9. 10.1086\/590004","journal-title":"Clin Infect Dis"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1086\/599105","article-title":"Recent advances in the management of mucormycosis: from bench to bedside","volume":"48","author":"Spellberg B","year":"2009","unstructured":"Spellberg B, Walsh TJ, Kontoyiannis DP, Edwards J Jr, Ibrahim AS. Recent advances in the management of mucormycosis: from bench to bedside. Clin Infect Dis. 2009, 48:1743-51. 10.1086\/599105","journal-title":"Clin Infect Dis"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(16)00071-2","article-title":"Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis","volume":"16","author":"Marty FM","year":"2016","unstructured":"Marty FM, Ostrosky-Zeichner L, Cornely OA, et al.. Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis. Lancet Infect Dis. 2016, 16:828-37. 10.1016\/S1473-3099(16)00071-2","journal-title":"Lancet Infect Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/485724-all-that-swells-is-not-allergy-unmasking-rhino-orbital-cerebral-mucormycosis-in-diabetic-ketoacidosis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T17:13:48Z","timestamp":1777482828000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/485724-all-that-swells-is-not-allergy-unmasking-rhino-orbital-cerebral-mucormycosis-in-diabetic-ketoacidosis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.107978","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,29]]}}}